fbpx

Scope 2022 – Summit for Clinical Ops Executives

Florida, USA

Summit for Clinical Ops Executives (SCOPE) will offer three stimulating days of in-depth discussions in 12 different conferences focused on issues related to each aspect of clinical trial planning and management.

The topics include:

Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Forecasting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, and Pharmacovigilance.

PharmaLedger Presence

PharmaLedger will be participating in a series of discussions called, “Applying Blockchain for End-to-End Clinivla Supply Management.” You can read about the discussions we will be participating below.

Optimizing and Accelerating Clinical Trials and Health Data Marketplace with Blockchain
Disa Lee Choun, Head, GCSO Innovation, UCB Pharma
Distributed Ledger Technology has been widely adopted in the Financial sector, unlike the Pharmaceutical and Healthcare industries. With the rise of digital health, e-patients, and patient empowerment, could blockchain be the game-changer? Could we optimize and accelerate the drug development process and access to better care? Learn more about PharmaLedger project and the Clinical Trial and Health Data Use Cases using IoT and machine learning.

PharmaLedger’s Journey through the eConsent Use Case

Baldwin C. Mak, Leader Strategic Feasibility & Manager, Clinical Trial Portfolio, Boehringer Ingelheim Canada
The global pandemic has accelerated changes in the way patients, physicians and other stakeholders conduct clinical trials through the use of digital technologies and remote interactions. Yet trust, transparency and security of data remains a concern which impacts patient engagement and confidence in the results. The e-consent use case aims to leverage the informed consent on blockchain technology to increase patient empowerment and to transform the future conduct of clinical trials by improving trust, transparency, and security. (please note that these abstracts are the same – one must be changed)

Powering Trust in Internet of Things (IoT) Trial Ecosystems
Maria Eugenia (Xenia) Beltran, PharmaLedger Project Coordinator, Universidad Politécnica de Madrid
Architectures for the IoT medical devices typically rely on transmitting data to centralized cloud servers which often generate isolated data silos in different medical devices platforms and concerns of trust and lack transparency in data processing, manipulation and concealment of IoT data. To overcome these downsides, the PharmaLedger IoT and Personalized Medicine use case provides data sharing schemas supporting data integrity and provenance, under consenting and domain-specific privacy principles.

PANEL DISCUSSION: Blockchain Consortium – The IMI PharmaLedger Project
PANEL MODERATOR:
Disa Lee Choun, Head, ICOA, Janssen UK
PANELISTS:
Maria Eugenia (Xenia) Beltran, PharmaLedger Project Coordinator, Universidad Politécnica de Madrid
Baldwin C. Mak, Leader Strategic Feasibility & Manager, Clinical Trial Portfolio, Boehringer Ingelheim Canada
Hernando C. Giraldo, Digital Laboratory, Scouting and Innovation, Boehringer Ingelheim Pharmaceuticals, Inc.
Lynn H Wang, Director, Product Management, Supply Chain Visibility, Johnson & Johnson

Contact

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.

Subscribe!

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.